ArticleNature communications2017

Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.

Edurne San José-Enériz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.